Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease
NEJM Evidence · 2024
DOI: 10.1056/evidoa2300189 ↗Kurz gefasst
Metaanalyse in der Zeitschrift NEJM Evidence, 2024. Verfasst von Jeffrey T Ha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Wollongong Hospital, Wollongong, NSW, Australia. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor-Proline Dioxygenases, Prolyl-Hydroxylase Inhibitors, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Renal Medicine, Wollongong Hospital, Wollongong, NSW, Australia.
- Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales Medicine & Health, Sydney.
- Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa.
- Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
- Department of Renal Medicine, University College London, London.
- Division of Nephrology, Washington University School of Medicine, St. Louis.
Zitieren
APA
Ha, J. T., Hiremath, S., Jun, M., Green, S. C., Wheeler, D. C., Coyne, D. W., Perkovic, V., & Badve, S. V. (2024). Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease. NEJM Evidence. https://doi.org/10.1056/evidoa2300189
Vancouver
Ha JT, Hiremath S, Jun M, Green SC, Wheeler DC, Coyne DW, et al. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease. NEJM Evidence. 2024. doi:10.1056/evidoa2300189
BibTeX
@article{Ha2024,
author = {Ha, Jeffrey T and Hiremath, Swapnil and Jun, Min and Green, Suetonia C and Wheeler, David C and Coyne, Daniel W and Perkovic, Vlado and Badve, Sunil V},
title = {Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease},
journal = {NEJM Evidence},
year = {2024},
doi = {10.1056/evidoa2300189}
}
EUVIMED